PharmaShots | Incisive News in 3 Shots

Subscribe Now

metastatic head and neck cancer

AstraZeneca's Imfinzi Fails to Meet its Primary Endpoints in P-III KESTREL Study

AstraZeneca's Imfinzi Fails to Meet its Primary Endpoints in P-III KESTREL Study

February 8, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us